Richard Adcock

Board Member

CEO

Equibles does not estimate personal net worth.

Get an email with a short summary when ImmunityBio, Inc. publishes a filing, an earnings call transcript or a press release.

Get IBRX alerts

About Richard Adcock

Richard Adcock is recorded as Board Member and CEO at ImmunityBio, Inc. (IBRX). The newest filing on record that lists Richard Adcock as Board Member and CEO at ImmunityBio, Inc. (IBRX) is dated April 30, 2026. The proxy statement of ImmunityBio, Inc. reports total compensation of $12,716,953 for Richard Adcock in fiscal 2025, including a base salary of $831,667. Disclosed compensation is on record for 6 fiscal years. Richard Adcock has spoken on 1 earnings call and 1 other investor event across 1 company, most recently for ImmunityBio, Inc. on March 10, 2026. ImmunityBio, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at ImmunityBio, Inc. includes Patrick Soon-Shiong (Chairman and Board Member), David Sachs (CFO and Chief Accounting Officer), Regan Lauer (Chief Accounting Officer) and 7 others.

Richard Adcock on recent calls

“If you've been following Immunity Bio, you've seen a lot of action as of recent. One of the things that I've told people for a long time is the biggest blessing in my life is the ability to work with Dr. Patrick Shunsheng, who's the founder of this.”

CEO, The Citizens Life Sciences Conference · March 10, 2026

“I appreciate you all joining us today, and I'm excited to walk you through what was truly a transformational year for ImmunityBio. Before I get into the numbers, I want to reinforce a point that Patrick made.”

CEO, ImmunityBio, Inc. Q4 FY2025 Earnings Call · January 15, 2026

Affiliation history

ImmunityBio, Inc. (IBRX)
SEC 8-K

Current
2021-03-05–present
ImmunityBio, Inc. (IBRX)
Board Member

Proxy statement

Current
Start not stated–present

Last confirmed April 30, 2026
ImmunityBio, Inc. (IBRX)
CEO

Proxy statement

Current
Start not stated–present

Last confirmed April 30, 2026

Company network

ImmunityBio, Inc.

IBRX

Current role

Biotechnology · Healthcare

Board Member, CEO

2021-03-05–present

2 appearances Latest appearance 2026-03-10

View calls and events

Leadership on record at ImmunityBio, Inc.

Patrick Soon-Shiong Chairman, Board Member
David Sachs CFO, Chief Accounting Officer
Regan Lauer Chief Accounting Officer
Barry J. Simon Board Member
Bruce Wendel Board Member
Cheryl L. Cohen Board Member
Christobel Selecky Board Member
John Brennan Board Member
Linda Maxwell Board Member
Michael D. Blaszyk Board Member

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year	Company	Role	Salary	Bonus	Stock awards	Option awards	Incentive	Other	Total
2025	ImmunityBio, Inc. (IBRX)	President and CEO	$831,667	$141,684	$2,787,828	$8,353,406	$485,166	$117,202	$12,716,953
2024	ImmunityBio, Inc. (IBRX)	Chief Executive Officer and President	$802,123	—	$2,396,341	$7,214,767	$477,600	$64,044	$10,954,875
2023	ImmunityBio, Inc. (IBRX)	Chief Executive Officer and President	$796,000	$298,500	—	—	—	$62,403	$1,156,903
2022	ImmunityBio, Inc. (IBRX)	Chief Executive Officer and President	$790,760	—	—	$3,159,057	—	$58,690	$4,008,507
2021	ImmunityBio, Inc. (IBRX)	Chief Executive Officer and President	$765,144	$57,656	$13,872,641	$13,969,483	$269,063	$82,740	$29,016,727
2020	ImmunityBio, Inc. (IBRX)	Chief Executive Officer and President	$141,347	$67,808	—	—	—	$1,731	$210,886

Recent activity

Conference The Citizens Life Sciences Conference ImmunityBio, Inc. (IBRX)
2026-03-10
Earnings call ImmunityBio, Inc. Q4 FY2025 Earnings Call ImmunityBio, Inc. (IBRX)
2026-01-15